Geneva, Feb. 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119026) titled 'Efficacy and Safety of Cilostazol Versus Aspirin for Secondary Prevention in Patients With Ischemic Stroke and Cerebral Microbleeds: A Real-World Cohort Study Using Propensity Score Matching' on Feb. 14.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Zhejiang Provincial People's Hospital
Condition:
Ischemic Stroke
Intervention:
Aspirin group:N/A
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-01
Target Sample Size: Aspirin group:480;Cilostazol group:120;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showp...